AARD Reports $110M Cash, $1.64 EPS, Voluntary Pause of PWS Phase 3 Trials, Guidance Q2 2026
Aardvark Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $3.99
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS